C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real Time Price. Currency in USD
30.30
-1.45 (-4.57%)
At close: Mar 27, 2026, 4:00 PM EDT
30.69
+0.39 (1.29%)
After-hours: Mar 27, 2026, 4:59 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
30.30
-1.45 (-4.57%)
At close: Mar 27, 2026, 4:00 PM EDT
30.69
+0.39 (1.29%)
After-hours: Mar 27, 2026, 4:59 PM EDT
This stock has a consensus price target of $50.17 based on the ratings of 14 analysts. The high is $90.00 and the low is $24.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 24 | $ 50.17 | $ 90 |
| Change | -20.79% | 65.58% | 197.03% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-03-02 | 12.21% | Goldman Sachs | $30 → $34 | Maintains | Neutral |
| 2026-02-26 | 124.42% | Stifel | $58 → $68 | Reiterates | Buy |
| 2025-12-17 | -20.79% | Barclays | $21 → $24 | Maintains | Underweight |
| 2025-11-11 | -30.69% | Barclays | $25 → $21 | Maintains | Underweight |
| 2025-10-21 | 58.42% | Mizuho | $48 | Initiates Coverage On | Outperform |